Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZhuFeng Project: Peg-IFN for Clinical Cure in Chronic Hepatitis B
NCT04035837Phase 4Active, not recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- May 2018
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Started May 2018; status: active, not recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04035837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04035837.